These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 16086622

  • 1. Mood alterations during interferon-alfa therapy in patients with chronic hepatitis C: evidence for an overlap between manic/hypomanic and depressive symptoms.
    Constant A, Castera L, Dantzer R, Couzigou P, de Ledinghen V, Demotes-Mainard J, Henry C.
    J Clin Psychiatry; 2005 Aug; 66(8):1050-7. PubMed ID: 16086622
    [Abstract] [Full Text] [Related]

  • 2. Psychiatric symptoms in patients with chronic hepatitis C receiving interferon alfa-2b therapy.
    Kraus MR, Schäfer A, Faller H, Csef H, Scheurlen M.
    J Clin Psychiatry; 2003 Jun; 64(6):708-14. PubMed ID: 12823087
    [Abstract] [Full Text] [Related]

  • 3. Subthreshold mania as predictor of depression during interferon treatment in HCV+ patients without current or lifetime psychiatric disorders.
    Dell'Osso L, Pini S, Maggi L, Rucci P, Del Debbio A, Carlini M, Baldini A, Ferrari G, Manca E, Beverini E, Amore M, Scarallo V, Semeraro Q, Brunetto M, Bonino F, Maj M.
    J Psychosom Res; 2007 Mar; 62(3):349-55. PubMed ID: 17324686
    [Abstract] [Full Text] [Related]

  • 4. [Impact of interferon alpha immunotherapy on tryptophan metabolism in patients with chronic hepatitis C. Results of a pilot studies on ten patients].
    Vignau J, Costisella O, Canva V, Imbenotte M, Duhamel A, Lhermitte M.
    Encephale; 2009 Oct; 35(5):477-83. PubMed ID: 19853722
    [Abstract] [Full Text] [Related]

  • 5. Depressive symptoms in patients with hepatitis C treated with pegylated interferon alpha therapy: a 24-week prospective study.
    Pavlović Z, Delić D, Marić NP, Vuković O, Jašović-Gašić M.
    Psychiatr Danub; 2011 Dec; 23(4):370-7. PubMed ID: 22075738
    [Abstract] [Full Text] [Related]

  • 6. [Alpha-interferon and mental disorders].
    Debien C, De Chouly De Lenclave MB, Foutrein P, Bailly D.
    Encephale; 2001 Dec; 27(4):308-17. PubMed ID: 11686052
    [Abstract] [Full Text] [Related]

  • 7. Hepatitis C treatment in patients with drug addiction: clinical management of interferon-alpha-associated psychiatric side effects.
    Schaefer M, Mauss S.
    Curr Drug Abuse Rev; 2008 Jun; 1(2):177-87. PubMed ID: 19630716
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The Effect of Combination Antiviral Therapy in the Treatment of Hepatitis C on the Occurrence of Depressive Disorder in Patients Treated for Hepatitis C in the Republic of Srpska.
    Banjac V, Zivlak-Radulovic N, Miskovic M.
    Med Arch; 2016 Apr; 70(2):127-30. PubMed ID: 27147788
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pegylated interferon and ribavirin-induced depression in chronic hepatitis C: role of personality.
    Castellvi P, Navinés R, Gutierrez F, Jiménez D, Márquez C, Subirà S, Solà R, Martín-Santos R.
    J Clin Psychiatry; 2009 Jun; 70(6):817-28. PubMed ID: 19573480
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Biological and psychological components of depression in patients receiving IFN-alpha therapy for hepatitis C.
    Małyszczak K, Inglot M, Frydecka D, Hadryś T, Pawłowski T.
    Adv Clin Exp Med; 2019 Sep; 28(9):1217-1222. PubMed ID: 30811903
    [Abstract] [Full Text] [Related]

  • 16. The mood spectrum in unipolar and bipolar disorder: arguments for a unitary approach.
    Cassano GB, Rucci P, Frank E, Fagiolini A, Dell'Osso L, Shear MK, Kupfer DJ.
    Am J Psychiatry; 2004 Jul; 161(7):1264-9. PubMed ID: 15229060
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Irritable-hostile depression: further validation as a bipolar depressive mixed state.
    Benazzi F, Akiskal H.
    J Affect Disord; 2005 Feb; 84(2-3):197-207. PubMed ID: 15708417
    [Abstract] [Full Text] [Related]

  • 19. Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system.
    Bonaccorso S, Marino V, Puzella A, Pasquini M, Biondi M, Artini M, Almerighi C, Verkerk R, Meltzer H, Maes M.
    J Clin Psychopharmacol; 2002 Feb; 22(1):86-90. PubMed ID: 11799348
    [Abstract] [Full Text] [Related]

  • 20. Psychiatric symptoms induced by antiviral therapy in chronic hepatitis C: comparison between interferon-alpha-2a and interferon-alpha-2b.
    Neri S, Pulvirenti D, Bertino G.
    Clin Drug Investig; 2006 Feb; 26(11):655-62. PubMed ID: 17163300
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.